Organoids as Models for Neoplastic Transformation
- PMID: 26907527
- DOI: 10.1146/annurev-pathol-012615-044249
Organoids as Models for Neoplastic Transformation
Abstract
Cancer models strive to recapitulate the incredible diversity inherent in human tumors. A key challenge in accurate tumor modeling lies in capturing the panoply of homo- and heterotypic cellular interactions within the context of a three-dimensional tissue microenvironment. To address this challenge, researchers have developed organotypic cancer models (organoids) that combine the 3D architecture of in vivo tissues with the experimental facility of 2D cell lines. Here we address the benefits and drawbacks of these systems, as well as their most recent advances. In particular, we focus on the application of such models to the discovery of novel cancer drivers, the study of tumor biology, and the development of novel therapeutic approaches for the treatment of cancer.
Keywords: 3D culture; cancer; organoid; organotypic.
Similar articles
-
Reconstructing the tumor architecture into organoids.Adv Drug Deliv Rev. 2021 Sep;176:113839. doi: 10.1016/j.addr.2021.113839. Epub 2021 Jun 19. Adv Drug Deliv Rev. 2021. PMID: 34153370 Free PMC article. Review.
-
Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment.Gene. 2019 Feb 20;686:203-212. doi: 10.1016/j.gene.2018.11.058. Epub 2018 Nov 24. Gene. 2019. PMID: 30481551 Review.
-
Tumor organoids: From inception to future in cancer research.Cancer Lett. 2019 Jul 10;454:120-133. doi: 10.1016/j.canlet.2019.04.005. Epub 2019 Apr 11. Cancer Lett. 2019. PMID: 30981763 Review.
-
Modeling neoplastic disease with spheroids and organoids.J Hematol Oncol. 2020 Jul 16;13(1):97. doi: 10.1186/s13045-020-00931-0. J Hematol Oncol. 2020. PMID: 32677979 Free PMC article. Review.
-
The potential application of organoids in breast cancer research and treatment.Hum Genet. 2022 Feb;141(2):193-208. doi: 10.1007/s00439-021-02390-0. Epub 2021 Oct 28. Hum Genet. 2022. PMID: 34713317 Review.
Cited by
-
Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review.J Ovarian Res. 2019 Nov 8;12(1):105. doi: 10.1186/s13048-019-0577-2. J Ovarian Res. 2019. PMID: 31703723 Free PMC article. Review.
-
Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma.Cancers (Basel). 2019 Aug 12;11(8):1156. doi: 10.3390/cancers11081156. Cancers (Basel). 2019. PMID: 31409002 Free PMC article. Review.
-
Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.Cancer Lett. 2018 Nov 1;436:109-118. doi: 10.1016/j.canlet.2018.08.017. Epub 2018 Aug 23. Cancer Lett. 2018. PMID: 30144514 Free PMC article.
-
Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making.J Pers Med. 2021 Dec 10;11(12):1348. doi: 10.3390/jpm11121348. J Pers Med. 2021. PMID: 34945820 Free PMC article. Review.
-
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.Br J Cancer. 2019 Mar;120(5):527-536. doi: 10.1038/s41416-018-0315-3. Epub 2019 Feb 6. Br J Cancer. 2019. PMID: 30723303 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
